Mineral
This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer
Chromium picolinate at 200-1,000 mcg/day has shown modest effects on body weight and composition. A 2013 meta-analysis found chromium reduced body weight by ~0.5 kg and body fat by ~0.46% vs placebo. Effects are small but may be more pronounced in overweight individuals with insulin resistance.
Chromium picolinate has mixed evidence for weight management. Meta-analyses consistently show statistically significant but clinically modest reductions in body weight (~0.5-1.1 kg) and body fat. The most interesting application may be for carbohydrate cravings and binge eating behavior, where effects appear more meaningful. It is likely most beneficial in insulin-resistant individuals where chromium insufficiency is more common.
Chromium picolinate has mixed evidence for weight management.
| Form | Bioavailability | Best For |
|---|---|---|
| Chromium Picolinate | Moderate | Most studied form — used in the majority of weight management trials |
| Chromium Polynicotinate | Moderate | Niacin-bound form — similar efficacy with potentially better tolerability |
General recommendation: 200-1,000 mcg daily
Timing: Take with meals; some prefer before carb-heavy meals • Take with food for best absorption.
| Condition | Recommended Dose | Evidence |
|---|---|---|
| Weight management | 200-1,000 mcg daily | Emerging |
| Carbohydrate cravings | 600-1,000 mcg daily | Emerging |
| Binge eating | 600-1,000 mcg daily | Emerging |
Upper limit: 1,000 mcg/day is the typical upper dose in trials; the IOM has not set a formal UL
Safety profile: Generally Safe
Evidence shows very modest weight loss (~0.5-1 kg) with chromium supplementation. It's not a powerful weight loss agent, but it may help by reducing carbohydrate cravings and improving insulin sensitivity. It is most useful as part of a comprehensive weight management strategy, particularly for individuals with insulin resistance.
Chromium enhances insulin receptor sensitivity, which may stabilize blood sugar fluctuations that trigger cravings. By improving glucose utilization by cells, it may reduce the brain's signal for more sugar. Clinical trials show reduced food intake and cravings at 600-1,000 mcg/day.
At doses up to 1,000 mcg/day, chromium picolinate is generally safe. Earlier concerns about DNA damage from picolinate were based on cell culture studies at supraphysiological concentrations and have not been confirmed in human studies. The IOM has not set a formal upper limit, reflecting the low toxicity risk.